Vanguard Group’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-12,067,939
Closed -$728M 4177
2016
Q2
$728M Buy
12,067,939
+370,888
+3% +$21M 0.05% 476
2016
Q1
$538M Buy
11,697,051
+328,021
+3% +$11.9M 0.03% 564
2015
Q4
$550M Buy
11,369,030
+458,889
+4% +$19.8M 0.04% 538
2015
Q3
$464M Buy
10,910,141
+302,013
+3% +$15M 0.03% 590
2015
Q2
$606M Buy
10,608,128
+678,368
+7% +$41.8M 0.04% 506
2015
Q1
$641M Buy
9,929,760
+589,814
+6% +$33.8M 0.04% 493
2014
Q4
$465M Buy
9,339,946
+454,194
+5% +$23.6M 0.03% 576
2014
Q3
$439M Buy
8,885,752
+101,104
+1% +$4.3M 0.03% 557
2014
Q2
$339M Sell
8,784,648
-323,492
-4% -$10.9M 0.03% 690
2014
Q1
$293M Buy
9,108,140
+695,824
+8% +$25.7M 0.02% 734
2013
Q4
$268M Buy
8,412,316
+330,638
+4% +$9.99M 0.02% 747
2013
Q3
$242M Buy
8,081,678
+235,518
+3% +$6.72M 0.02% 740
2013
Q2
$193M Buy
+7,846,160
New +$197M 0.02% 794

Other funds holding MDVN

Vanguard Group's MDVN Position: Q3 2016 in Review

Vanguard Group sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 12,067,939 shares — an estimated $728M sold.

Vanguard Group first reported a position in MDVN in Q2 2013 and held it in 13 quarters. The position peaked at $728M in Q2 2016. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • Vanguard Group reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • Vanguard Group sold 12,067,939 MEDIVATION, INC. shares in Q3 2016, an estimated $728M.
  • Vanguard Group first reported a position in MEDIVATION, INC. in Q2 2013 and held it in 13 quarters.
  • Vanguard Group's MEDIVATION, INC. position peaked at $728M in Q2 2016.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on Vanguard Group's 13F filing for Q3 2016, filed 14 Nov 2016.